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Cox Swvival Eatimalea
SDNN ASDNN5 SDANN5
50 ma 150 ma 20 ma 60 ma 40 ms 140 ma
1 yr 0.92 0.97 0.90 0.98 0.92 0.97
2 yrs 0.80 0.93 0.77 0.95 0.81 0.93
to2.4fold increase in risk.Thus, in chronic coronary disease decreased HRV
should be considered an important marker for increased long-term mortality
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m7316 The Effect of Beta-Blockers on Recovery of HeartRate Variability in the Beta Blocker Hesrt Attack Trial
(BHAT)
R.J. Lampert, J.R. Ickovics, C.M. Viscoli, L.E. Rosepfeld, R.1.Horwitz,
F.A. Lee. Yale School of Medicine, New Haven, CT USA
Heart rate variability(HRV), a predictor of post-Ml mortality, is depressed
immediately poet-Ml and recovers partially over time. To evaluate the effect
of beta blocker (BB) on recovery of HRV post-Ml, we analyzed HRV parem-
etem from 24-hour Holters recorded one week post-Ml and 6 weeks later
in 68 propanolol- and 98 placebc-treated male BHAT study pts (age 53.8 +
9.1). Baseline frequency domain HRV parameters (log-transformed) did not
differ betweengroups. High frequency (HF) power, an index of vagal tone,
increased more over 6 weeks in BB compared to placebo group: 4,28+0.08
to 5.17 * 0.08 in BB vs 4.25 + 0.08 to 4.78 & 0.08 in placebo, p <0.05.
Sympetho-vagal balance measured by the low frequency (LF) to HF ratio
increased in placebo pte (1.03 + 0.05 to 1.17 + 0.05) but decreased in the
BB group (1.09 + 0.05 to 0.96 + 0.05), a significant difference (p < 0.01).
The increase over 6 weeks in ultra low, very low, LF,and total power was not
affected by BB. At 6 weeks, the morning increase in LF/HF was blunted by
BB (p < 0.05).
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In post-Ml pts, BB therapy significantly improves fi?coveryof parasym-
pathetic tone and alters sympatho-vagal balance, particularly on awakening.
These findings may elucidate mechanisms by which BBs decrease mortality
and reduce tire early morning risk of sudden death prst-Ml.
n732 Newer Therapyfor AtrialFibrillation
Tuesday, March 18, 1997, 8:30 a.m.–l O:OOa.m.
Anaheim Convention Center, Room B1
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El7321 Biatrial Linear and Focal Ablation For ReetoringSinua Rhythm [n Patiente With Refractory Atrial
Fibrillation: Initial Experience With A Two Staged
Prooedure
J.D. Maloney, V. Chodimella, A. Sabe, F.O. Mkparu, L. Milner, M.L. Markel,
Ohio Heart Care, 4455 Dreasler RoadrVw, Canton, OH, USA
Radiofrequency catheter ablation (RFCA) has gained wide acceptance as a
therepyformost atrial tachyarrhythmias with the excluaionof atrial fibrillation.
Initial RFCAexperience suggeatathat extensive anatomic-electrophysiologic
substrate (AES) modification of both atria can be an antidote for refractory
chronic atrial fibrillation (CAF): but residual atrial tachycardias have been
frequent. Therefore a two staged biatrial linear and focal ablation (BALF) pro-
cedure was designed to address previous limitations including excessively
prolonged procedures and high morbidity. A two staged BALF procedure for
8 patients (pts) was pertormed to cure CAF with and without structural heart
disease. A total of 14 BALF-CAF procedures were performed averaging 5
hours and 100 lesions per procedure. Left atrial accees was obtained by
transseptal Brockenbraugh needle in 5/8 pts and 7/14 procedures. Observa-
tions and Results: Left atrial linear lesions were generally followed by more
organized and focal tachycardias, most commonly identified around the pul-
monary vein os and left atrial appendage. Sudden reversion to sinus rhythm
occurs with additional focal RFCA. Recurrence of tachycardias prior to stage
2 is commonly focal and atypical for CAF. Stage 2 always included focal
RFCA plus repeated linear lesions. No thromboembolic complications were
obsetved. Normal sinua rhythm was reatored in all patients transiently, main-
tained in 5/6 pts that underwent stage 2, with mean follow-up of 3 months.
Atrial funtiion as measured by atrial contflbution to mitral valve inflow, as
well as atrial dimension appears to have improved over an average period of
2 months following BALF.
Conckrsions:1). A two staged BALFcan modi~ AES in pts with CAFwith
restoration of sinus rhythm and limited morbidity. 2). Repeat left atrial access
is usually achievable without use of Brockenbraugh needle if performed
within 6 weeks. 3). The change in atrial tachycardia morphology with multiple
lesions may provide inaights into mechanisms of CAF. 4). BALF appears to
restore and maintain sinus rhythm in selected patients.
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1732-21Atrial MaPPin9and Effectiveneasof aRi9ht Atria,
Cathater Ablation in Patients with Vagal Atrial
Fibrillation
F.Gaita, R. Riccardi, M. Scaglione, F. Lemberti, E. Richiardi, L. Calb,
L. Garberoglio, R. Maasa, M. Bocchiardo, S. MiceIi. Division of Cardio/og~
Hospita/ of Asti, /fa/y
Experimental evidences suggested that in patients (pte) with vagal (V) atrial
fibrillation (AF) the right atrium (A) is generally primarily involved in the
maintenance of the AF. Aim of this work was to evaluate the efficacy and
safety of a new procedure of CA for V AF with a right atrial approach.
Fourteen consecutive pts (mean age 52,*10 yeare) with V AF, all highly
symptomatic for palpitations and refracto~ to all antiarrhythmic druga, un-
derwent RF CA. Nine pts had daily sustained paroxysmal AF and 5 had
persistent AF. In all the pts mapping of both right A, using special multieleo-
trode catheters, for a total of 40 electrodes, and left was performed. Three
anatomic lesions were performed in the right A: a) from the superior vena
cava (VC) to the fossa ovalis and from this to the inferior VC; b) in the infe-
rior VC-tricuspid annqlus isthmus and c) a transversal lesion from the fossa
ovalis to the lateral edge of the tricuspid annulus. Special catheters with multi
4 mm electrodes. Success of the ablation was considered if no recurrences
of AF occurred either without or with previously ineffective drugs.
In 9 pts atrial mapping showed a regular rapid atrial activity in the lateral
rightAwhile it was irregular,and fragmented in the septal region. In5 pts sinus
rhythm was restored during RF delivery preceded by a gradual organization
of the atrial activity and in 1 at the end of the procedure. No complications
occurred in any pt.
In the follow-up (range 4-16 months) 6 pts did not have AF recurrences (3
treated with previously ineffective drug therapy). Five pts had AF recurrences
and 3 had atrial flutter. Four of the latter 6 were aaymptomatic for palpitations,
although no differences of the heart rate was observed before and after the
ablation.
In conclusion ablation of V AF with a right atrial procedure is possible,
showing that in aome pts the right A is primary involved in the genesisof this
arrhythmia.
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1732-31 RadiofreWencYCatheter Ab,ationoftheRi9ht
Atrium for Control of Atrial Fibrillation Refractory to
Antiarrhythmic Druga
G. FeId, U. Birgersdotter-Green, 0. Fijumura, K. Undesser. University of
California, San Diego, CA, USA
/ntroduction:The Mezeoperation cencureatrialfibrillation (AF).Therefore, we
postulated that long Iinearradiofrequency catheter ablation (RFCA) leaions in
therightatrium (RA), combined with tricuspid valve-inferior venacevaiathmus
(TV-WC) ablation would also modify the substrate for AF, and either prevent
its recurrence or make it easier to control with antiarrhythmic drugs (AAD).
Methods: Vertical linear RFCA of the posterior, septal, and anterior RA and
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TV-IVC was performed using 4or8 mm electrode catheters in6 patients (pts)
with a histoty of symptomatic AF. All pts were cardiovetiad to sinus rhythm
(SR) before ablation. All pte were male. Mean age was 57 + 10 yre. AF
(duration 4.5 + 3.7 yre) was uncontrolled by a minimum of 3 AADs (class 1
or 3), amiodarone (AM), or both. Three pts had coronary disease, 1 pt had
hypetiension, and 2 pta had no cardiac disease. Two pts had prior successful
RFCA for atrial flutter with persistent bidirectional conduction block in the
TV-IVC. After ablation, pts were treated with sotalol (3 pts), AM (2 pts), or
no AAD (1 pt), and followed up every 3 months with a physical examination,
ECG and aeeeeementof symptoms for recurrent AF. Resu/fa:There were no
complications during this study,and all ptswere in SRatdischarge. Procedure
time wee <6 hra in all pte, but mean fluoroscmpytime was 137 + 55 minutes.
During follow-up of 10 +4 months, 5 pts have baanfree of recurrentAFand 1
pf has only rare peroxyemal AF. Conclusions: Linear RAplus TV-WC isthmus
ablation, with or without AAD, may reduce or eliminate recurrences of AF in
some pts, possibly by modifying the substrate for AF.
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~32-4\ ARandO~i~~d~~~~W~~,v~~~u~Y~f~u~,~i~~A~~i~,
Pacingforthe PreventionofAtrialFibrillation
P.A. Friedman, M.R.S. Hill, D.L. Hayes, M.S. Stanton. Mayo Clinic,
Rochestec MN, USA, Medtronic Inc., Minneapolis, MN, USA
Seckgrowrd: Previous non-randomized studies have suggestad that pacing
from two right atrial sites decreases the frequency of recurrences of parox-
ysmal atrial fibrillation (PAF).
Methods and Results: Nine patients age 72 + 6 yrs with at least two
episodes par month of symptomatic PAF in the preceding 3 months received
pacemakers with an atnal ‘Y” mnnacfor permitting single site atrial pacing in
the high right atrium (HRA) alone, or dual atrial pacing (DAP) between the
HRA and a second atrial lead actively fixed posterior to the coronav sinus
OS.Patients were randomized to three separate three month blocks of HRA
pacing (DDDR 60), DAP (DDDR 80) and supporf pacing (DDD 50-80) in
a crossover study design. At enrollment, seven patients had symptomatic
techy-bredy syndrome, and 2 patients underwent AV node ablation for PAF.
Patients had a mean ejection fraction of 60 + 15%, left atrial size of 49 + 7
mm, and had failed 2 + 1 antiarrhyfhmic drugs. Implant thresholds were 0.6
+ 0.1 V HRA and 1.5 + 0.6 V os (p < 0.005) and P wave amplitudes 2.6+
1 mV HRA vs 2.1 + 0.8 mV os (p = NS). DAP resulted in shorter P wave
duration, and a different P wave morphology.
Pre PPM DAP HRA Suppon
Pwave(ins) 123 + 9 81 * 14* 111*12 123 +10
Arrhythmiafree interval(days) 14*11 74& 26 68 k 38 62 +39
*p <0.01
There were no lead dislodgement, or significant threshold rises.
Conclusion: (1) Dual atrial pacing is feasible and safe, (2) DAP alters
the atrial activation sequence, (3) atrial pacing tends to decrease the time
to recurrence of PAF, (4) whether DAP provides any benefit beyond that of
HRA pacing alone is unclear and requires further study.
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El7325 TheDIGAFetudy(DigoxininAtrielFibrillation):Revereionof etrielfibrillationwithhighdoaedigoxin
(preliminaryreaulta)
H.G. StOhlinger,H. Domanovits, G. Gamper, U. Hollenstein, K. Janata,
W. Behringer, A.N. Leggner. Errrerg.Dept., Univ. of Vienna,Austria
hrtroductiorr Digoxin is used in atrial fibrillation (AF) to control the ventricular
response. Antiarrhythmic effects on the atrial level have not been proven.
However, conversion to sinus rhythm in patients on digitalis alone is well
known. While some authors report success rates up to 93%, othera find an
incidence of conversion to ainus rhythm equal to or even below spontaneous
occurrence. Thia might be due to dosing and mode of application as well
as reflect the inhomogeneity of patients with AF. Parenteral application, high
doses and fast achievement of therapeutic aerum levels all seem to favour
conversion.
Hypothesis: In AF conversion to sinus rhythm by digitalis ia dose depen-
dent. With high doses conversion rates are high.
Methods: Patients (AF < 46 hours) were randomized to digoxin or
placebo. Both groups were treated with two doses of 12.5 mg of diltiezem.
Digoxin waadosedasfollows: 0.4mg on admiaaion and30 min. later. 0.2-0.6
mg (accordin9 to patient’s weight) after 4 hours and 0.4 mg after 12 hours.
The maximal dose waa 1.6 mg. Patients were monitored for 18 hours. Car-
diovereion waa recorded via Helter ECG monitoring. Patients on permanent
antiarrhythmic drugs or suffering from coronav or pulmonary diseases were
excluded from the study.
Resu/ts.’37patients have been evaluated so far(17 patients who received
digoxin, 20inthe placebo group). 16/17 patients in the digoxin group (94.2%)
reverted to sinus rhythm during the observation period. in the control group
only 10 out of 20 patients (50%) developed sinus rhythm within 16 houra.
This difference waa statistically aignificent.
Conclusion: Acute AF can be converted to sinus rhythm with high doses
of digoxin in the majority of cases. Success rate are considerably higher than
with diltiazem alone.
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R.G. Trohman, S.L. Pinaki, K.A. Mowrey, M.J. Niebauer, E.J. Schlosa,
P.J.Tchou. C/eve/andC/inic Foundation, Cleveland, Ohio, USA
Direct-currentcardlovereion is the most effective way to restore sinus rhythm
in pts with atrial fibrillation (AF). However, external cardioveraion with cur-
rently available maximal energies is ineffective in 15Y0of pts. Internal cer-
dioveraion has been used for these refractory patients, but is invasive and
requires discontinuation of protective anticoagulation. We hypothesized that
delivery of noninvasive, external high-energy synchronized shocks by simul-
taneous triggering of two cardioverter unite over 4 patch electrodes could
safely restore sinus rhythm in these pts. We studied 11 AF pts who failed
external cerdioveraion with at least two (2.5 +0.5) 360 J-shocks. There were
7 men (84%), age 55 + 12, most were obese (body mass index 35 + 6
kgh+), and 82Y0were on antiarrhyfhmic drugs (amiodarone in 45~o). Sinus
rhythm was restored in 9 (82%) after a median of one 720 J-shock (mean
1.33 + 0.5). No pt developed hemodynamic compromise or congestive hearl
failure. One unsuccessful pt (on amiodarone) developad transient RBBB,
and later that day had bradycardia-induced toreade de pointes. Recovery
was uneventful after pacemaker implantation. Another pt with unsuccessful
conversion underwent successful internal cardioversion at a later date.
Conclusions: 1) External delivery of higher current density with the same
peak voltage restores sinus rhythm in the majority of refractory AF pts with-
out producing clinical evidence of myocardiai impairment. 2) This procedure
may be considered as an alternative to internal cardiovemion since it per-
mits continued anticoagulation during the critical periprocedurel period. 3) A
randomized controlled trial of both methods seems justifiable.
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~ TheEff~~tofRemodelin~on DiateneibilitYin
AtheroscleroticFemoralArteries:A Post-Mortem
IntravascularUltrasoundStudy
B.J. Osaenkoppele, G. Peeterkamp, L.J. Bos, W.J. van Wolferen, B. Hillen,
C. Borst. Heart-Lung Institute and Department of Functional Anatomy
Utn?chtUniversity Hospital, Utrecht, The Natherfands
Atherosclerotic arteries display either no remodeling or two diatincf types
of remodeling: shrinkage, which accelerates lumen narrowing; and com-
pensatory enlargement, which decelerates lumen narrowing. To investigate
whether distinctly remodeled segments possess different mechanical prop-
erties, 12 femoral arteries were infused post mortem in situ with saline at 5
different pressures (40, 60, 120, 180, and 240 mmHg). At each ixessure,
lumen area (LA) and vessel area (VA)were measured at 1cm inte~als using
intravascular ultrasound. In each arterial segment, the cross-section with the
least amount of plaque was used as a reference. Remodeling was calculated
as (VANA (ref))* 100%. Three groups were created: group 1- remodeling
<95%, indicating shrinkage; group 2 – remodeling between 95 and 1050/.,
indicating lack of remodeling; group 3 – remodeling >105%, indicating en-
largement. The LA at 40 mmHg was used as an initial value to which all
Pressure Group 1 (n= 37) Group2(n=33) Group3 (n =93)
% LAl D % LAl D “/0Ml D
80 mmHg: 20.2”/0”$ 5.o*# 8.2”AY 2.1 3.20/n 0.s
120 mmHg 24.7”/&*# 3.1*# 16.8% 2,1 7.8”h 1.0
160 mmH~ 31.6%” 2.6* 19.s% 1,7 in n.k# ~ *#. . . . .
240 mmH~ 32.8”/n* 1.6* 26.2% 1.3 11.o”/&# l.1#
(*P < 0.05 c0mPared withgroup3, #p < 0.05 compared With group2)
